What the research says about polycystic ovary syndrome, fertility, and why no two cases look alike
Two women can walk out of two different clinics on the same afternoon with the same diagnosis — polycystic ovary syndrome — and live completely different stories. One is pregnant within the year. The other spends the next two or three years cycling through specialists, medications, and one question she can’t shake: what is wrong with my body?
Same three letters. Very different roads. And that difference isn’t luck, and it isn’t willpower. There’s real science explaining why one woman with PCOS conceives easily and another struggles.
The name causes unnecessary panic. Those ovarian “cysts” aren’t dangerous growths — they’re small, immature follicles, each holding an egg that started developing and then stalled before release. Hold that image: not damaged ovaries, but ovaries full of eggs that got stuck partway.
PCOS affects roughly one in ten women of reproductive age and is the leading cause of infertility related to irregular ovulation.
Diagnosis uses the Rotterdam criteria — three features, and you need any two:
That “two of three” is the master key. Women arrive at PCOS through different doors — which is exactly why no two cases look alike.
Every combination of those criteria produces a different version of PCOS, called a phenotype:
Type A — the complete form. All three features at once. On average the most metabolically serious: the most insulin resistance, the most difficulty with weight and blood sugar, and often the hardest fertility road.
Type B — high androgens plus irregular ovulation, with normal-appearing ovaries. Still firmly on the more serious end.
Type C — “ovulatory PCOS.” High androgens and polycystic ovaries, but regular ovulation. Because these women still release an egg most months, their odds of conceiving naturally are dramatically better — and metabolically this is the mildest of the classic types. In one study of 274 women, 65% of type C patients were a normal weight, versus 43% of types A and D.
Type D — irregular ovulation with normal androgens. Often the gentlest metabolic picture.
The practical takeaway: severity tracks with two things — whether you’re still ovulating, and how far out of balance your androgens and insulin are. So the most useful question for your doctor isn’t “do I have PCOS?” It’s “which type do I have, and what does that mean for me?”
Twin studies estimate PCOS is roughly 70% heritable — the same neighborhood as height. Daughters of women with PCOS have about a five-fold higher risk, and male relatives show elevated rates of insulin resistance and type 2 diabetes. PCOS is really a family metabolic trait that expresses itself most visibly in the ovaries.
Genes load the gun; lifestyle and environment influence whether and how it fires. You didn’t cause the underlying condition — but how severely it expresses is something you and your care team can genuinely influence.
If you understand one mechanism, make it this one. Insulin resistance sits underneath a great deal of PCOS.
Insulin moves sugar from your bloodstream into your cells. When cells stop responding properly, the body compensates by producing more and more insulin. Blood sugar can look normal on a basic test while chronically high insulin circulates all day.
That high insulin does two things inside the ovary. It drives androgen production — which is why the insulin problem and the testosterone problem travel together. And it disrupts the brain-to-ovary signaling that selects one follicle each month and matures it to ovulation. Instead of one follicle taking the lead, a crowd stalls partway — and that arrested crowd is exactly the “polycystic” appearance on ultrasound.
Follow the chain: insulin resistance → high insulin → high androgens and scrambled signaling → stalled follicles → no ovulation, no period, no chance to conceive that cycle. An estimated 65–70% of women with PCOS have insulin resistance.
A word from our sponsor — Larson Nutrition
That insulin-and-androgen loop is exactly what Larson Nutrition helps women work on. Founder Kim Larson built her practice after her own metabolic wake-up call and has since worked with more than three thousand clients on insulin resistance, prediabetes, metabolic syndrome, and PCOS — through personalized nutrition protocols built around your actual numbers, real biomarker monitoring, and weekly one-on-one accountability coaching. It’s designed to complement your medical care, not replace it. Learn more at LarsonNutrition.com.
About 80% of women with PCOS are overweight, and excess weight genuinely worsens insulin resistance. But one in five is lean — normal weight, full-blown PCOS.
Here’s the striking part: insulin resistance affects an estimated 75% of lean women with PCOS, compared with 95% of those who are overweight. The metabolic glitch is built into the condition itself. Researchers describe lean women as having intrinsic insulin resistance that’s part of the syndrome, while heavier women carry that plus an added layer from excess weight.
This matters because lean women are often told they “can’t” have PCOS, and their metabolic risks go unmonitored simply because they don’t fit the stereotype. Whatever your size: PCOS is a metabolic and hormonal condition — not a moral failing, and not a matter of willpower.
It comes down to one word: ovulation. To conceive naturally, you need to release a mature egg — and that’s the step that breaks down for many women with PCOS.
But here’s what surprises people, and it’s the opposite of what most women fear. Women with PCOS usually aren’t running low on eggs — quite the reverse. They typically have more eggs than average, which is exactly why AMH runs high and the ovary looks so full on a scan.
The problem isn’t supply. It’s release. The eggs are there — often in abundance. They’re just getting stuck before the finish line. Picture a room full of candidates and a doorway that isn’t opening reliably. And a stuck doorway is often something medicine is very good at helping to open.
Lifestyle comes first. Because insulin sits at the center, improving metabolic health can restart ovulation on its own — for women carrying extra weight, even a 5–10% loss can be enough. This isn’t about crash diets; it’s a sustainable approach to food, movement, sleep, and stress.
If medication is needed, letrozole is now the guideline’s preferred first-line drug, outperforming older clomiphene in the pivotal trial — about 27.5% versus 19.1% live births, with a lower risk of twins.
Supporting options include metformin and inositol supplements (a myo-inositol/d-chiro-inositol blend that supports insulin signaling; one meta-analysis found it improved menstrual regularity more than metformin alone).
Newer GLP-1 medications like semaglutide can improve weight and metabolic markers — but they are not fertility drugs and aren’t safe in pregnancy. Because they can trigger unexpected ovulation, contraception is advised while taking them, with a washout period before trying to conceive.
Higher rungs — injectable hormones and IVF — are there if needed, and IVF works well in PCOS because there are so many eggs to work with. Most women never climb that far.
Most women with PCOS have children. A 25-year cohort study found that while they had slightly fewer children on average and were more likely to have their first at a later age, they reported the same family aspirations as women without PCOS — and large numbers achieved them. Even teenagers with irregular, PCOS-type cycles overwhelmingly went on to conceive, many without ever needing treatment.
One honest caveat: pregnancy with PCOS carries somewhat higher risks — gestational diabetes and high blood pressure are roughly twice as common. That’s a reason for attentive prenatal care, not fear.
PCOS reaches beyond fertility — into skin and hair changes, long-term diabetes and heart risk, and a real mental-health burden. Anxiety and depression are meaningfully more common, and that deserves genuine support. Chronic stress nudges the very hormones already out of balance, so rest and recovery aren’t indulgences — they’re maintenance.
A word from our sponsor — Larson Botanicals
Caring for your body from the outside in matters too. Larson Botanicals makes organic-ingredient skincare and hand-crafted candles — clean, plant-powered self-care. A candle won’t balance your hormones, but when you’re managing something as relentless as PCOS, the small rituals matter: a routine that feels good on a hard morning, a few quiet minutes that belong only to you. Explore it at LarsonBotanicals.com.
This article is general information, not medical advice. Please talk with your own clinician about your situation.
Sources: 2023 International Evidence-based Guideline for PCOS (JCEM); Dutch twin-family heritability study (Vink et al.); lean vs. obese PCOS meta-analysis (Frontiers in Endocrinology, 2025); letrozole vs. clomiphene trial (Legro et al.); inositol network meta-analysis; 25-year fertility cohort (AJOG, 2024).
